MARKET STRUCTURE IN BIOTECHNOLOGY: IMPLICATIONS FOR LONG-RUN COMPARATIVE ADVANTAGE

Vista sencilla de ítem
dc.creatorLavoie, Brian F.
dc.creatorSheldon, Ian M.
dc.date2017-04-01T14:14:28Z
dc.date.accessioned2026-07-09T03:37:08Z
dc.descriptionA country specializing in a high technology industry may find that excess returns stemming from innovation are reallocated overseas as foreign-based multinationals access ongoing domestic R&D through alliances with or acquisition of established domestic start-ups. Computer simulation illustrates this process in the context of the current US specialization in biotechnology. Keywords: Biotechnology, market structure, comparative advantage
dc.identifierdoi:10.22004/ag.econ.21835
dc.identifierhttps://ageconsearch.umn.edu/record/21835/files/sp00la03.pdf
dc.identifierhttp://ageconsearch.umn.edu/record/21835
dc.identifier.urihttp://hdl.handle.net/123456789/536664
dc.languageeng
dc.publisher
dc.sourcehttp://ageconsearch.umn.edu/record/21835
dc.titleMARKET STRUCTURE IN BIOTECHNOLOGY: IMPLICATIONS FOR LONG-RUN COMPARATIVE ADVANTAGE
dc.typeText

Archivos

Colecciones

University of Minnesota